Lisinopril Tablet
Product Images NDC 51655-146

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lisinopril (NDC 51655-146). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lisinopril (133b3fec 07f6 41f5 9c7c 50b66c4c0677 01)

Lisinopril (133b3fec 07f6 41f5 9c7c 50b66c4c0677 01)
Chemical structure diagram of Lisinopril showing its molecular composition with various functional groups and atoms, including the presence of water molecules (2H2O).*
FDA Label Image

Label (51655 146 26)

Label (51655 146 26)
Label for Lisinopril Tablets USP 40 mg, oral tablet form, containing 90 tablets. Labeled for prescription use only and produced by Northwind Health Company, LLC. The label includes storage instructions, dosage referral to package insert, and identifies the product NDC as 51655-146-26.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.